{"id":340188,"date":"2025-08-20T10:37:44","date_gmt":"2025-08-20T10:37:44","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-elevance-health\/"},"modified":"2025-08-20T10:37:44","modified_gmt":"2025-08-20T10:37:44","slug":"how-to-buy-elevance-health","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/","title":{"rendered":"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340188","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Elevance Health, Inc. (ELV) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. ELV hisse performans\u0131, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Elevance Health, Inc. (ELV) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. ELV hisse performans\u0131, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Portf\u00f6y\u00fcn\u00fcze bir sa\u011fl\u0131k devi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Elevance Health, Amerika'n\u0131n en b\u00fcy\u00fck sa\u011fl\u0131k faydas\u0131 \u015firketlerinden biri olarak, devasa 4 trilyon dolarl\u0131k sa\u011fl\u0131k sekt\u00f6r\u00fcnde istikrar ve b\u00fcy\u00fcme potansiyeli sunuyor. Milyonlarca \u00fcyesi ve yenilik\u00e7i dijital sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleriyle, bu hisse portf\u00f6y sa\u011fl\u0131\u011f\u0131n\u0131z i\u00e7in re\u00e7eteniz olabilir.","intro_source":{"label":"Intro","type":"text","formatted_value":"Portf\u00f6y\u00fcn\u00fcze bir sa\u011fl\u0131k devi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Elevance Health, Amerika'n\u0131n en b\u00fcy\u00fck sa\u011fl\u0131k faydas\u0131 \u015firketlerinden biri olarak, devasa 4 trilyon dolarl\u0131k sa\u011fl\u0131k sekt\u00f6r\u00fcnde istikrar ve b\u00fcy\u00fcme potansiyeli sunuyor. Milyonlarca \u00fcyesi ve yenilik\u00e7i dijital sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleriyle, bu hisse portf\u00f6y sa\u011fl\u0131\u011f\u0131n\u0131z i\u00e7in re\u00e7eteniz olabilir."},"body_html":"<h2>\ud83d\udcc8 Elevance Health Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla, Elevance Health, Inc. (ELV) NYSE'de <strong>312,00 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Bu fiyat, y\u0131llard\u0131r g\u00f6r\u00fclmeyen bir f\u0131rsat\u0131 temsil ediyor - hisse senedi, \u00f6nemli piyasa dalgalanmalar\u0131n\u0131n ard\u0131ndan 52 haftal\u0131k aral\u0131\u011f\u0131n\u0131n alt s\u0131n\u0131r\u0131na yak\u0131n konumda.<\/p> <p><strong>Takviminize Not Edin: 16 Ekim 2025<\/strong> - bu tarih yat\u0131r\u0131m getirilerinizi dramatik \u015fekilde de\u011fi\u015ftirebilir. Elevance Health, piyasa a\u00e7\u0131lmadan \u00f6nce 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyreklik duyurular \u00f6nemli fiyat hareketleri yaratm\u0131\u015ft\u0131r.<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3> <p>\u00d6nceki kazan\u00e7 raporlar\u0131n\u0131n ELV hissesini nas\u0131l etkiledi\u011fine bakal\u0131m:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><th>Analiz<\/th><\/tr> <\/thead> <tbody> <tr><td>17 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>305 $<\/td><td>-%3,8 (EPS beklenti alt\u0131nda)<\/td><td>Gelir beklentiyi a\u015ft\u0131 ancak EPS hayal k\u0131r\u0131kl\u0131\u011f\u0131<\/td><\/tr> <tr><td>22 Nisan 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>320 $<\/td><td>+%5,2 (EPS beklentiyi a\u015ft\u0131)<\/td><td>B\u00f6l\u00fcmler genelinde g\u00fc\u00e7l\u00fc performans<\/td><\/tr> <tr><td>23 Ocak 2025<\/td><td>4. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>335 $<\/td><td>-%0,5 (hafif beklenti alt\u0131nda)<\/td><td>Kar\u0131\u015f\u0131k sonu\u00e7lar, rehberlik endi\u015feleri<\/td><\/tr> <tr><td>17 Ekim 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>380 $<\/td><td>-%13,4 (b\u00fcy\u00fck beklenti alt\u0131nda)<\/td><td>\u00d6nemli maliyet bask\u0131s\u0131 sorunlar\u0131<\/td><\/tr> <\/tbody> <\/table> <p><strong>Desen \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif s\u00fcrprizler genellikle g\u00fcnler i\u00e7inde %5-8 kazan\u00e7 sa\u011flarken, negatif sonu\u00e7lar %10-15 d\u00fc\u015f\u00fc\u015fe neden olabilir. En son 2. \u00e7eyrek raporu, gelir beklentiyi 1 milyar dolar a\u015fsa da (<a href=\"https:\/\/www.elevancehealth.com\/newsroom\/elv-quarterly-earnings-q2-2025\">2. \u00c7eyrek 2025 Sonu\u00e7lar\u0131<\/a>), EPS beklentisi alt\u0131nda kalmas\u0131 hisseyi d\u00fc\u015f\u00fcrd\u00fc.<\/p> <h3>6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h3> <p>Elevance Health hisseleri son alt\u0131 ayda ini\u015f \u00e7\u0131k\u0131\u015flar ya\u015fad\u0131:<\/p> <p><strong>\u015eubat 2025<\/strong>: 340 $ - 4. \u00e7eyrek sonu\u00e7lar\u0131n\u0131n ard\u0131ndan g\u00fc\u00e7l\u00fc ba\u015flang\u0131\u00e7<br\/> <strong>Mart 2025<\/strong>: 315 $ - D\u00fczenleyici endi\u015feler ortaya \u00e7\u0131kt\u0131<br\/> <strong>May\u0131s 2025<\/strong>: 290 $ - Maliyet trend endi\u015feleriyle 52 haftal\u0131k dip<br\/> <strong>Temmuz 2025<\/strong>: 305 $ - 2. \u00e7eyrek kazan\u00e7 tepkisi kar\u0131\u015f\u0131k<br\/> <strong>A\u011fustos 2025<\/strong>: 312 $ - Son toparlanma ivmesi<\/p> <p>Hisse bu d\u00f6nemde yakla\u015f\u0131k <strong>%8,2<\/strong> de\u011fer kaybetti ve genel sa\u011fl\u0131k sekt\u00f6r\u00fc performans\u0131n\u0131n olduk\u00e7a gerisinde kald\u0131. Ancak, son ayl\u0131k %13,21 kazan\u00e7 (<a href=\"https:\/\/www.tradingview.com\/symbols\/NYSE-ELV\/\">TradingView Verileri<\/a>) potansiyel bir d\u00f6n\u00fc\u015f momentumunu i\u015faret ediyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, beklenenler \u015funlar:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 410-450 $ aral\u0131\u011f\u0131 (%32-44 y\u00fckseli\u015f) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br\/> Analistler ortalama 411,86 $ fiyat hedefi ile \"Al\" tavsiyesinde birle\u015fiyor (<a href=\"https:\/\/stockanalysis.com\/stocks\/elv\/forecast\/\">StockAnalysis Tahmini<\/a>). Mevcut F\/K oran\u0131 13,3x, tarihsel ortalamalar\u0131n alt\u0131nda olup, de\u011ferinin alt\u0131nda oldu\u011funu g\u00f6steriyor.<\/p> <p><strong>2026 Projeksiyonu<\/strong>: 480-520 $<br\/> Carelon platformunun \u00f6l\u00e7eklenmesi ve de\u011fer bazl\u0131 bak\u0131m giri\u015fimlerinin olgunla\u015fmas\u0131yla EPS b\u00fcy\u00fcmesinin %14'e h\u0131zlanmas\u0131.<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 580-630 $<br\/> Pazar liderli\u011fi konsolidasyonu ve dijital sa\u011fl\u0131k hakimiyeti s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcmeyi destekliyor.<\/p> <p><strong>2030 Vizyonu<\/strong>: 600-650+ $<br\/> K\u00fcresel sa\u011fl\u0131k geni\u015flemesi ve ya\u015flanan n\u00fcfus demografisi uzun vadeli destek sa\u011fl\u0131yor.<\/p> <p><strong>Karar<\/strong>: Mevcut seviyeler uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in ola\u011fan\u00fcst\u00fc bir giri\u015f noktas\u0131 sunuyor. Risk-getiri oran\u0131 birikimi destekliyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici Engeller<\/strong>: Medicare Advantage \u00f6demelerinde ve Medicaid programlar\u0131nda olas\u0131 de\u011fi\u015fiklikler k\u00e2rl\u0131l\u0131\u011f\u0131 etkileyebilir (<a href=\"https:\/\/monexa.ai\/blog\/elevance-health-navigating-regulatory-challenges-a-ELV-2025-02-27\">D\u00fczenleyici Zorluklar<\/a>). Sa\u011fl\u0131k sigortas\u0131 sekt\u00f6r\u00fc s\u00fcrekli politika belirsizli\u011fi ile kar\u015f\u0131 kar\u015f\u0131ya.<\/li> <li><strong>Hukuki Zorluklar<\/strong>: Birden fazla menkul k\u0131ymetler toplu dava, fiyatlar\u0131 yapay olarak \u015fi\u015firdi\u011fi iddias\u0131yla dava a\u00e7t\u0131 (<a href=\"https:\/\/www.monexa.ai\/blog\/elevance-health-elv-lawsuits-investor-implications-ELV-2025-06-17\">Hukuki S\u00fcre\u00e7ler<\/a>). Temmuz 2025 bu davalarda kritik tarihlerdi.<\/li> <li><strong>T\u0131bbi Maliyet Enflasyonu<\/strong>: \u00d6zellikle Medicare Advantage planlar\u0131nda t\u0131bbi maliyetlerin s\u00fcrekli y\u00fckselmesi marjlar \u00fczerinde bask\u0131 yarat\u0131yor. 2. \u00e7eyrek 2025, ACA pazarlar\u0131nda artan maliyet trendlerini g\u00f6sterdi.<\/li> <li><strong>Rekabetin Yo\u011funla\u015fmas\u0131<\/strong>: Hem geleneksel sigortac\u0131lar hem de teknoloji odakl\u0131 yeni oyuncular sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fc d\u00f6n\u00fc\u015ft\u00fcr\u00fcyor.<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Mali G\u00fc\u00e7<\/strong>: 2. \u00e7eyrek geliri 49,4 milyar $ ile y\u0131ll\u0131k %14,3 b\u00fcy\u00fcme g\u00f6sterdi (<a href=\"https:\/\/www.elevancehealth.com\/newsroom\/elv-quarterly-earnings-q2-2025\">Kazan\u00e7 Raporu<\/a>). \u015eirket g\u00fc\u00e7l\u00fc nakit \u00fcretimini s\u00fcrd\u00fcr\u00fcyor.<\/li> <li><strong>Pazar Konumu<\/strong>: 46 milyon t\u0131bbi \u00fcye ve bir\u00e7ok eyalette Blue Cross Blue Shield lisans\u0131 g\u00fc\u00e7l\u00fc rekabet avantajlar\u0131 yarat\u0131yor.<\/li> <li><strong>Dijital D\u00f6n\u00fc\u015f\u00fcm<\/strong>: Sydney Health platformu ve Health OS, verimlili\u011fi ve m\u00fc\u015fteri ba\u011fl\u0131l\u0131\u011f\u0131n\u0131 art\u0131ran ki\u015fiselle\u015ftirilmi\u015f \u00fcye deneyimleri sunuyor.<\/li> <li><strong>De\u011fer Bazl\u0131 Bak\u0131m Liderli\u011fi<\/strong>: Sa\u011fl\u0131k harcamalar\u0131n\u0131n %66's\u0131n\u0131n de\u011fer bazl\u0131 anla\u015fmalarda olmas\u0131, ELV'yi sekt\u00f6r d\u00f6n\u00fc\u015f\u00fcm\u00fcnde lider konuma getiriyor.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ul> <li><strong>Stratejik Birikim<\/strong>: K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131n ve piyasa zay\u0131fl\u0131\u011f\u0131nda art\u0131r\u0131n. Mevcut de\u011ferleme g\u00fcvenlik marj\u0131 sa\u011fl\u0131yor.<\/li> <li><strong>Kazan\u00e7 Zamanlamas\u0131<\/strong>: 16 Ekim kazan\u00e7lar\u0131ndan \u00f6nce pozisyon a\u00e7may\u0131 d\u00fc\u015f\u00fcn\u00fcn ancak volatiliteye haz\u0131rl\u0131kl\u0131 olun. Tarihsel desenler potansiyel f\u0131rsat g\u00f6steriyor.<\/li> <li><strong>\u00c7e\u015fitlendirme Dengesi<\/strong>: Sekt\u00f6re \u00f6zg\u00fc riskler nedeniyle ELV'yi toplam portf\u00f6y\u00fcn %5-10'u ile s\u0131n\u0131rlay\u0131n.<\/li> <li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: \"ELV ticareti sa\u011fl\u0131k gibidir - bazen iyile\u015fme s\u00fcrecinde sab\u0131r gerekir. Ama hastane faturalar\u0131n\u0131n aksine, dikkatli olursan\u0131z bu hisse sizi iflasa s\u00fcr\u00fcklemez!\"<\/li> <\/ul> <h2>\u2705 Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ticaret Platformu Se\u00e7in<\/td><td>NYSE eri\u015fimi ve d\u00fc\u015f\u00fck komisyon yap\u0131s\u0131 sa\u011flay\u0131n<\/td><\/tr> <tr><td>2<\/td><td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n - 500 $ bile pozisyon a\u00e7maya yeterli<\/td><\/tr> <tr><td>3<\/td><td>\"ELV\" Ticker'\u0131n\u0131 Aray\u0131n<\/td><td>\u015eirket ad\u0131 aramas\u0131 yapmay\u0131n, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Limit emirleri ani fiyat s\u0131\u00e7ramalar\u0131na kar\u015f\u0131 korur<\/td><\/tr> <tr><td>5<\/td><td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc Belirleyin<\/td><td>Risk tolerans\u0131 ve portf\u00f6y da\u011f\u0131l\u0131m\u0131na g\u00f6re hisse say\u0131s\u0131n\u0131 belirleyin<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Onaylamadan \u00f6nce emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Performans\u0131 Takip Edin<\/td><td>Kazan\u00e7 tarihleri ve teknik seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, ELV gibi hisselerde pozisyon olu\u015fturmak i\u00e7in ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile stratejileri denemeye ve g\u00fcven kazanmaya ba\u015flayabilirsiniz. Bu eri\u015filebilirlik geleneksel giri\u015f engellerini kald\u0131r\u0131r.<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek bir belge ile 1 dakikal\u0131k KYC s\u00fcreci sayesinde onay i\u00e7in g\u00fcnlerce beklemeden hemen i\u015flem yapmaya ba\u015flayabilirsiniz.<\/li> <li><strong>Esnek Para \u00c7ekme<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100'den fazla \u00e7ekim y\u00f6ntemi, kar al\u0131m\u0131nda benzersiz esneklik sa\u011flar.<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, Elevance Health, Inc. (ELV) hisseleri nas\u0131l al\u0131n\u0131r stratejinizi tamamen yeni ba\u015flayanlar i\u00e7in bile kolayla\u015ft\u0131r\u0131r.<\/p> <h2>\ud83c\udf0d 2025'te Elevance Health: Sa\u011fl\u0131kta Dijital \u00d6nc\u00fc<\/h2> <p>Elevance Health, 46 milyon t\u0131bbi \u00fcyeye hizmet veren Amerikan sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn devlerinden biridir ve \u00e7e\u015fitlendirilmi\u015f sa\u011fl\u0131k faydalar\u0131 platformu \u00fczerinden faaliyet g\u00f6stermektedir. \u015eirket, Sa\u011fl\u0131k Faydalar\u0131, CarelonRx, Carelon Hizmetleri ve Kurumsal operasyonlar olmak \u00fczere d\u00f6rt ana segmentte yakla\u015f\u0131k 190 milyar dolar y\u0131ll\u0131k gelir elde etmektedir.<\/p> <p>Geleneksel sigortan\u0131n \u00f6tesinde, ELV dijital sa\u011fl\u0131k devriminde Sydney Health platformu ile ki\u015fiselle\u015ftirilmi\u015f \u00fcye deneyimleri yaratmaktad\u0131r. \u015eirketin de\u011fer bazl\u0131 bak\u0131ma (sa\u011fl\u0131k harcamalar\u0131n\u0131n %66's\u0131) olan ba\u011fl\u0131l\u0131\u011f\u0131, sonu\u00e7 odakl\u0131 modellere do\u011fru sekt\u00f6r d\u00f6n\u00fc\u015f\u00fcm\u00fcnde \u00f6nc\u00fc konumda olmas\u0131n\u0131 sa\u011flamaktad\u0131r.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Elevance Health, k\u0131rsal topluluklarda sa\u011fl\u0131k profesyoneli eksikli\u011fini ele alan burs programlar\u0131na yak\u0131n zamanda yat\u0131r\u0131m yapt\u0131 (<a href=\"https:\/\/www.elevancehealth.com\/newsroom\">\u015eirket Duyurular\u0131<\/a>). Bu giri\u015fim sadece topluluk sa\u011fl\u0131\u011f\u0131n\u0131 desteklemekle kalmay\u0131p, ayn\u0131 zamanda gelece\u011fin yetenek havuzlar\u0131n\u0131 olu\u015fturuyor - tipik Wall Street analizlerinin s\u0131kl\u0131kla g\u00f6zden ka\u00e7\u0131rd\u0131\u011f\u0131 parlak uzun vadeli stratejik bir hamle!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Elevance Health Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla, Elevance Health, Inc. (ELV) NYSE&#8217;de <strong>312,00 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Bu fiyat, y\u0131llard\u0131r g\u00f6r\u00fclmeyen bir f\u0131rsat\u0131 temsil ediyor &#8211; hisse senedi, \u00f6nemli piyasa dalgalanmalar\u0131n\u0131n ard\u0131ndan 52 haftal\u0131k aral\u0131\u011f\u0131n\u0131n alt s\u0131n\u0131r\u0131na yak\u0131n konumda.<\/p>\n<p><strong>Takviminize Not Edin: 16 Ekim 2025<\/strong> &#8211; bu tarih yat\u0131r\u0131m getirilerinizi dramatik \u015fekilde de\u011fi\u015ftirebilir. Elevance Health, piyasa a\u00e7\u0131lmadan \u00f6nce 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyreklik duyurular \u00f6nemli fiyat hareketleri yaratm\u0131\u015ft\u0131r.<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3>\n<p>\u00d6nceki kazan\u00e7 raporlar\u0131n\u0131n ELV hissesini nas\u0131l etkiledi\u011fine bakal\u0131m:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<th>Analiz<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>17 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>305 $<\/td>\n<td>-%3,8 (EPS beklenti alt\u0131nda)<\/td>\n<td>Gelir beklentiyi a\u015ft\u0131 ancak EPS hayal k\u0131r\u0131kl\u0131\u011f\u0131<\/td>\n<\/tr>\n<tr>\n<td>22 Nisan 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>320 $<\/td>\n<td>+%5,2 (EPS beklentiyi a\u015ft\u0131)<\/td>\n<td>B\u00f6l\u00fcmler genelinde g\u00fc\u00e7l\u00fc performans<\/td>\n<\/tr>\n<tr>\n<td>23 Ocak 2025<\/td>\n<td>4. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>335 $<\/td>\n<td>-%0,5 (hafif beklenti alt\u0131nda)<\/td>\n<td>Kar\u0131\u015f\u0131k sonu\u00e7lar, rehberlik endi\u015feleri<\/td>\n<\/tr>\n<tr>\n<td>17 Ekim 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>380 $<\/td>\n<td>-%13,4 (b\u00fcy\u00fck beklenti alt\u0131nda)<\/td>\n<td>\u00d6nemli maliyet bask\u0131s\u0131 sorunlar\u0131<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Desen \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif s\u00fcrprizler genellikle g\u00fcnler i\u00e7inde %5-8 kazan\u00e7 sa\u011flarken, negatif sonu\u00e7lar %10-15 d\u00fc\u015f\u00fc\u015fe neden olabilir. En son 2. \u00e7eyrek raporu, gelir beklentiyi 1 milyar dolar a\u015fsa da (<a href=\"https:\/\/www.elevancehealth.com\/newsroom\/elv-quarterly-earnings-q2-2025\">2. \u00c7eyrek 2025 Sonu\u00e7lar\u0131<\/a>), EPS beklentisi alt\u0131nda kalmas\u0131 hisseyi d\u00fc\u015f\u00fcrd\u00fc.<\/p>\n<h3>6 Ayl\u0131k Fiyat Seyri (\u015eubat-A\u011fustos 2025)<\/h3>\n<p>Elevance Health hisseleri son alt\u0131 ayda ini\u015f \u00e7\u0131k\u0131\u015flar ya\u015fad\u0131:<\/p>\n<p><strong>\u015eubat 2025<\/strong>: 340 $ &#8211; 4. \u00e7eyrek sonu\u00e7lar\u0131n\u0131n ard\u0131ndan g\u00fc\u00e7l\u00fc ba\u015flang\u0131\u00e7<br \/> <strong>Mart 2025<\/strong>: 315 $ &#8211; D\u00fczenleyici endi\u015feler ortaya \u00e7\u0131kt\u0131<br \/> <strong>May\u0131s 2025<\/strong>: 290 $ &#8211; Maliyet trend endi\u015feleriyle 52 haftal\u0131k dip<br \/> <strong>Temmuz 2025<\/strong>: 305 $ &#8211; 2. \u00e7eyrek kazan\u00e7 tepkisi kar\u0131\u015f\u0131k<br \/> <strong>A\u011fustos 2025<\/strong>: 312 $ &#8211; Son toparlanma ivmesi<\/p>\n<p>Hisse bu d\u00f6nemde yakla\u015f\u0131k <strong>%8,2<\/strong> de\u011fer kaybetti ve genel sa\u011fl\u0131k sekt\u00f6r\u00fc performans\u0131n\u0131n olduk\u00e7a gerisinde kald\u0131. Ancak, son ayl\u0131k %13,21 kazan\u00e7 (<a href=\"https:\/\/www.tradingview.com\/symbols\/NYSE-ELV\/\">TradingView Verileri<\/a>) potansiyel bir d\u00f6n\u00fc\u015f momentumunu i\u015faret ediyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, beklenenler \u015funlar:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 410-450 $ aral\u0131\u011f\u0131 (%32-44 y\u00fckseli\u015f) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> Analistler ortalama 411,86 $ fiyat hedefi ile &#8220;Al&#8221; tavsiyesinde birle\u015fiyor (<a href=\"https:\/\/stockanalysis.com\/stocks\/elv\/forecast\/\">StockAnalysis Tahmini<\/a>). Mevcut F\/K oran\u0131 13,3x, tarihsel ortalamalar\u0131n alt\u0131nda olup, de\u011ferinin alt\u0131nda oldu\u011funu g\u00f6steriyor.<\/p>\n<p><strong>2026 Projeksiyonu<\/strong>: 480-520 $<br \/> Carelon platformunun \u00f6l\u00e7eklenmesi ve de\u011fer bazl\u0131 bak\u0131m giri\u015fimlerinin olgunla\u015fmas\u0131yla EPS b\u00fcy\u00fcmesinin %14&#8217;e h\u0131zlanmas\u0131.<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 580-630 $<br \/> Pazar liderli\u011fi konsolidasyonu ve dijital sa\u011fl\u0131k hakimiyeti s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcmeyi destekliyor.<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 600-650+ $<br \/> K\u00fcresel sa\u011fl\u0131k geni\u015flemesi ve ya\u015flanan n\u00fcfus demografisi uzun vadeli destek sa\u011fl\u0131yor.<\/p>\n<p><strong>Karar<\/strong>: Mevcut seviyeler uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in ola\u011fan\u00fcst\u00fc bir giri\u015f noktas\u0131 sunuyor. Risk-getiri oran\u0131 birikimi destekliyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici Engeller<\/strong>: Medicare Advantage \u00f6demelerinde ve Medicaid programlar\u0131nda olas\u0131 de\u011fi\u015fiklikler k\u00e2rl\u0131l\u0131\u011f\u0131 etkileyebilir (<a href=\"https:\/\/monexa.ai\/blog\/elevance-health-navigating-regulatory-challenges-a-ELV-2025-02-27\">D\u00fczenleyici Zorluklar<\/a>). Sa\u011fl\u0131k sigortas\u0131 sekt\u00f6r\u00fc s\u00fcrekli politika belirsizli\u011fi ile kar\u015f\u0131 kar\u015f\u0131ya.<\/li>\n<li><strong>Hukuki Zorluklar<\/strong>: Birden fazla menkul k\u0131ymetler toplu dava, fiyatlar\u0131 yapay olarak \u015fi\u015firdi\u011fi iddias\u0131yla dava a\u00e7t\u0131 (<a href=\"https:\/\/www.monexa.ai\/blog\/elevance-health-elv-lawsuits-investor-implications-ELV-2025-06-17\">Hukuki S\u00fcre\u00e7ler<\/a>). Temmuz 2025 bu davalarda kritik tarihlerdi.<\/li>\n<li><strong>T\u0131bbi Maliyet Enflasyonu<\/strong>: \u00d6zellikle Medicare Advantage planlar\u0131nda t\u0131bbi maliyetlerin s\u00fcrekli y\u00fckselmesi marjlar \u00fczerinde bask\u0131 yarat\u0131yor. 2. \u00e7eyrek 2025, ACA pazarlar\u0131nda artan maliyet trendlerini g\u00f6sterdi.<\/li>\n<li><strong>Rekabetin Yo\u011funla\u015fmas\u0131<\/strong>: Hem geleneksel sigortac\u0131lar hem de teknoloji odakl\u0131 yeni oyuncular sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fc d\u00f6n\u00fc\u015ft\u00fcr\u00fcyor.<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Mali G\u00fc\u00e7<\/strong>: 2. \u00e7eyrek geliri 49,4 milyar $ ile y\u0131ll\u0131k %14,3 b\u00fcy\u00fcme g\u00f6sterdi (<a href=\"https:\/\/www.elevancehealth.com\/newsroom\/elv-quarterly-earnings-q2-2025\">Kazan\u00e7 Raporu<\/a>). \u015eirket g\u00fc\u00e7l\u00fc nakit \u00fcretimini s\u00fcrd\u00fcr\u00fcyor.<\/li>\n<li><strong>Pazar Konumu<\/strong>: 46 milyon t\u0131bbi \u00fcye ve bir\u00e7ok eyalette Blue Cross Blue Shield lisans\u0131 g\u00fc\u00e7l\u00fc rekabet avantajlar\u0131 yarat\u0131yor.<\/li>\n<li><strong>Dijital D\u00f6n\u00fc\u015f\u00fcm<\/strong>: Sydney Health platformu ve Health OS, verimlili\u011fi ve m\u00fc\u015fteri ba\u011fl\u0131l\u0131\u011f\u0131n\u0131 art\u0131ran ki\u015fiselle\u015ftirilmi\u015f \u00fcye deneyimleri sunuyor.<\/li>\n<li><strong>De\u011fer Bazl\u0131 Bak\u0131m Liderli\u011fi<\/strong>: Sa\u011fl\u0131k harcamalar\u0131n\u0131n %66&#8217;s\u0131n\u0131n de\u011fer bazl\u0131 anla\u015fmalarda olmas\u0131, ELV&#8217;yi sekt\u00f6r d\u00f6n\u00fc\u015f\u00fcm\u00fcnde lider konuma getiriyor.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ul>\n<li><strong>Stratejik Birikim<\/strong>: K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131n ve piyasa zay\u0131fl\u0131\u011f\u0131nda art\u0131r\u0131n. Mevcut de\u011ferleme g\u00fcvenlik marj\u0131 sa\u011fl\u0131yor.<\/li>\n<li><strong>Kazan\u00e7 Zamanlamas\u0131<\/strong>: 16 Ekim kazan\u00e7lar\u0131ndan \u00f6nce pozisyon a\u00e7may\u0131 d\u00fc\u015f\u00fcn\u00fcn ancak volatiliteye haz\u0131rl\u0131kl\u0131 olun. Tarihsel desenler potansiyel f\u0131rsat g\u00f6steriyor.<\/li>\n<li><strong>\u00c7e\u015fitlendirme Dengesi<\/strong>: Sekt\u00f6re \u00f6zg\u00fc riskler nedeniyle ELV&#8217;yi toplam portf\u00f6y\u00fcn %5-10&#8217;u ile s\u0131n\u0131rlay\u0131n.<\/li>\n<li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: &#8220;ELV ticareti sa\u011fl\u0131k gibidir &#8211; bazen iyile\u015fme s\u00fcrecinde sab\u0131r gerekir. Ama hastane faturalar\u0131n\u0131n aksine, dikkatli olursan\u0131z bu hisse sizi iflasa s\u00fcr\u00fcklemez!&#8221;<\/li>\n<\/ul>\n<h2>\u2705 Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ticaret Platformu Se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve d\u00fc\u015f\u00fck komisyon yap\u0131s\u0131 sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n &#8211; 500 $ bile pozisyon a\u00e7maya yeterli<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;ELV&#8221; Ticker&#8217;\u0131n\u0131 Aray\u0131n<\/td>\n<td>\u015eirket ad\u0131 aramas\u0131 yapmay\u0131n, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Limit emirleri ani fiyat s\u0131\u00e7ramalar\u0131na kar\u015f\u0131 korur<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc Belirleyin<\/td>\n<td>Risk tolerans\u0131 ve portf\u00f6y da\u011f\u0131l\u0131m\u0131na g\u00f6re hisse say\u0131s\u0131n\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Onaylamadan \u00f6nce emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Performans\u0131 Takip Edin<\/td>\n<td>Kazan\u00e7 tarihleri ve teknik seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, ELV gibi hisselerde pozisyon olu\u015fturmak i\u00e7in ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile stratejileri denemeye ve g\u00fcven kazanmaya ba\u015flayabilirsiniz. Bu eri\u015filebilirlik geleneksel giri\u015f engellerini kald\u0131r\u0131r.<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek bir belge ile 1 dakikal\u0131k KYC s\u00fcreci sayesinde onay i\u00e7in g\u00fcnlerce beklemeden hemen i\u015flem yapmaya ba\u015flayabilirsiniz.<\/li>\n<li><strong>Esnek Para \u00c7ekme<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100&#8217;den fazla \u00e7ekim y\u00f6ntemi, kar al\u0131m\u0131nda benzersiz esneklik sa\u011flar.<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, Elevance Health, Inc. (ELV) hisseleri nas\u0131l al\u0131n\u0131r stratejinizi tamamen yeni ba\u015flayanlar i\u00e7in bile kolayla\u015ft\u0131r\u0131r.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Elevance Health: Sa\u011fl\u0131kta Dijital \u00d6nc\u00fc<\/h2>\n<p>Elevance Health, 46 milyon t\u0131bbi \u00fcyeye hizmet veren Amerikan sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn devlerinden biridir ve \u00e7e\u015fitlendirilmi\u015f sa\u011fl\u0131k faydalar\u0131 platformu \u00fczerinden faaliyet g\u00f6stermektedir. \u015eirket, Sa\u011fl\u0131k Faydalar\u0131, CarelonRx, Carelon Hizmetleri ve Kurumsal operasyonlar olmak \u00fczere d\u00f6rt ana segmentte yakla\u015f\u0131k 190 milyar dolar y\u0131ll\u0131k gelir elde etmektedir.<\/p>\n<p>Geleneksel sigortan\u0131n \u00f6tesinde, ELV dijital sa\u011fl\u0131k devriminde Sydney Health platformu ile ki\u015fiselle\u015ftirilmi\u015f \u00fcye deneyimleri yaratmaktad\u0131r. \u015eirketin de\u011fer bazl\u0131 bak\u0131ma (sa\u011fl\u0131k harcamalar\u0131n\u0131n %66&#8217;s\u0131) olan ba\u011fl\u0131l\u0131\u011f\u0131, sonu\u00e7 odakl\u0131 modellere do\u011fru sekt\u00f6r d\u00f6n\u00fc\u015f\u00fcm\u00fcnde \u00f6nc\u00fc konumda olmas\u0131n\u0131 sa\u011flamaktad\u0131r.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Elevance Health, k\u0131rsal topluluklarda sa\u011fl\u0131k profesyoneli eksikli\u011fini ele alan burs programlar\u0131na yak\u0131n zamanda yat\u0131r\u0131m yapt\u0131 (<a href=\"https:\/\/www.elevancehealth.com\/newsroom\">\u015eirket Duyurular\u0131<\/a>). Bu giri\u015fim sadece topluluk sa\u011fl\u0131\u011f\u0131n\u0131 desteklemekle kalmay\u0131p, ayn\u0131 zamanda gelece\u011fin yetenek havuzlar\u0131n\u0131 olu\u015fturuyor &#8211; tipik Wall Street analizlerinin s\u0131kl\u0131kla g\u00f6zden ka\u00e7\u0131rd\u0131\u011f\u0131 parlak uzun vadeli stratejik bir hamle!<\/p>\n"},"faq":[{"question":"Elevance Health hisseleri nereden al\u0131nabilir?","answer":"Elevance Health hisseleri, NYSE'de i\u015flem g\u00f6ren bir hisse senedidir ve \u00e7o\u011fu b\u00fcy\u00fck \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Elevance Health hissesi almak i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 platforma ba\u011fl\u0131d\u0131r ancak Pocket Option gibi baz\u0131 platformlarda sadece 5 $ ile i\u015flem yapmaya ba\u015flayabilirsiniz."},{"question":"Elevance Health hisselerinin 2025-2030 fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda hisse fiyat\u0131 410-450 $ aral\u0131\u011f\u0131nda olabilir ve 2030'a kadar 600-650 $ veya daha y\u00fcksek seviyelere ula\u015fmas\u0131 beklenmektedir."},{"question":"Elevance Health hissesi al\u0131rken hangi riskler dikkate al\u0131nmal\u0131d\u0131r?","answer":"D\u00fczenleyici de\u011fi\u015fiklikler, hukuki davalar, t\u0131bbi maliyet enflasyonu ve artan rekabet gibi riskler g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131d\u0131r."},{"question":"Yeni ba\u015flayanlar Elevance Health hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p piyasa zay\u0131fl\u0131\u011f\u0131nda art\u0131rmak, kazan\u00e7 raporlar\u0131 \u00f6ncesi pozisyon a\u00e7mak ve portf\u00f6yde ELV'yi %5-10 aras\u0131nda tutmak \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Elevance Health hisseleri nereden al\u0131nabilir?","answer":"Elevance Health hisseleri, NYSE'de i\u015flem g\u00f6ren bir hisse senedidir ve \u00e7o\u011fu b\u00fcy\u00fck \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Elevance Health hissesi almak i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 platforma ba\u011fl\u0131d\u0131r ancak Pocket Option gibi baz\u0131 platformlarda sadece 5 $ ile i\u015flem yapmaya ba\u015flayabilirsiniz."},{"question":"Elevance Health hisselerinin 2025-2030 fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda hisse fiyat\u0131 410-450 $ aral\u0131\u011f\u0131nda olabilir ve 2030'a kadar 600-650 $ veya daha y\u00fcksek seviyelere ula\u015fmas\u0131 beklenmektedir."},{"question":"Elevance Health hissesi al\u0131rken hangi riskler dikkate al\u0131nmal\u0131d\u0131r?","answer":"D\u00fczenleyici de\u011fi\u015fiklikler, hukuki davalar, t\u0131bbi maliyet enflasyonu ve artan rekabet gibi riskler g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131d\u0131r."},{"question":"Yeni ba\u015flayanlar Elevance Health hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p piyasa zay\u0131fl\u0131\u011f\u0131nda art\u0131rmak, kazan\u00e7 raporlar\u0131 \u00f6ncesi pozisyon a\u00e7mak ve portf\u00f6yde ELV'yi %5-10 aras\u0131nda tutmak \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T10:37:44+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T10:37:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/\",\"name\":\"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-20T10:37:44+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/","og_locale":"tr_TR","og_type":"article","og_title":"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T10:37:44+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T10:37:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/","name":"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r - Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-20T10:37:44+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-elevance-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Elevance Health, Inc. (ELV) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Elevance Health, Inc. (ELV) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":340185,"slug":"how-to-buy-elevance-health","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Elevance Health, Inc. (ELV) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Elevance Health, Inc. (ELV)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-elevance-health\/"},"pt_AA":{"locale":"pt_AA","id":340180,"slug":"how-to-buy-elevance-health","post_title":"Como comprar a\u00e7\u00f5es da Elevance Health, Inc. (ELV) - Investimento em a\u00e7\u00f5es da Elevance Health, Inc. (ELV)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-elevance-health\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=340188"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340188\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=340188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=340188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=340188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}